SCHEMBL6947674

SCHEMBL6947674

NCCON=C(CCCCn1ccnc1)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 5/20 0.62
CYP1A2 P05177 3/20 0.62
CYP3A4 P08684 3/20 0.62
CYP2D6 P10635 3/20 0.62
CYP2C9 P11712 3/20 0.62
CYP2C19 P33261 3/20 0.62
HIF1A Q16665 2/20 0.62
MEN1 O00255 2/20 0.62
LMNA P02545 2/20 0.62
KMT2A Q03164 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
NFKB1 P19838 1/20 0.62
SLC6A2 P23975 1/20 0.62
ADRA1A P35348 1/20 0.62
OPRK1 P41145 1/20 0.62
SLC6A3 Q01959 1/20 0.62
KCNH2 Q12809 1/20 0.62
SCN5A Q14524 1/20 0.62
SIGMAR1 Q99720 1/20 0.62
NOS1 P29475 4/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6953057 0.99 SLC6A4 (0.61) SLC6A4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6952666 0.97 SLC6A4 (0.60) SLC6A4CYP1A2CYP3A4CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL6950740 0.96 SLC6A4 (0.59) SLC6A4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6948590 0.93 CYP1A2 (0.56) SLC6A4CYP1A2CYP3A4CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL6949500 0.92 CYP1A2 (0.55) SLC6A4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6950846 0.85 SLC6A4 (0.58) SLC6A4CYP1A2CYP3A4CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL8667500 0.84 SLC6A4 (0.57) SLC6A4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6947048 0.83 SLC6A4 (0.58) SLC6A4SMN1; SMN2TBXA2R
SCHEMBL6952895 0.83 TBXA2R (0.59) SLC6A4MEN1LMNAKMT2ATBXA2R
Hydrochloric Acid SCHEMBL6950832 0.82 SLC6A4 (0.57) SLC6A4KMT2ASMN1; SMN2TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709378-B1 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds AVENTIS PHARMA INC (US) 2003-03-19 EP claimed
US-5696142-A TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-12-09 US claimed
EP-0709378-A2 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1996-05-01 EP claimed